General Counsel · Arcus Biosciences, Inc. (RCUS)

Carolyn Tang

A named executive officer of Arcus Biosciences in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,916,407

Salary $400,000Stock awards $460,521

FY2020: $2,239,445

6th of 6 named executive officers at Arcus Biosciences by FY2021 total.

6 named officers on file for Arcus Biosciences, FY2021

Carolyn Tang’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • RCUS’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Arcus Biosciences’s whole pay program stands against its peers

  • Arcus Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RCUS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Carolyn Tang’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Carolyn Tang compensation by year

Arcus Biosciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Arcus Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$337,515$400,000
Bonus$0$0
Stock awards$958,650$460,521
Option awards$767,080$1,852,686
Non-equity incentive$175,000$200,000
Pension and deferred compensation$0$0
All other$1,200$3,200
Total$2,239,445$2,916,407

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcus Biosciences, Inc. DEF 14A filed April 20, 2022, accession 0000950170-22-005855, and prior-year filings.

How this page was built: the Arcus Biosciences, Inc. filed document, accession 0000950170-22-005855. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2022.

$2.2M
$2.9M
FY20
FY21
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU24,750$1,001,633—
RSU9,403$380,539—
Option60,964—$9.12
Option5,000—$14.47
Option10,833—$9.47
Option6,771—$11.86
Option52,083—$11.68
Option57,986—$36.73

Per the Outstanding Equity Awards at Fiscal Year-End table in Arcus Biosciences, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

8 Form 4 lines since the FY2021 proxy (filed April 20, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-11Exercise or conversion derivative—34,090$2.570
2026-06-11Exercise or conversion—34,090$2.57184,607
2026-01-23Grant or award derivative—96,000$0.0096,000
2026-01-23Grant or award—24,000$0.00148,734
2025-12-17Sale10b5-16,810$22.16124,734
2025-12-16Sale10b5-17,658$21.88131,544
2025-01-23Grant or award derivative—150,000$0.00150,000
2025-01-23Grant or award—37,000$0.00137,623

The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Arcus Biosciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Jennifer JarrettChief Operating Officer$15,520,200
Terry RosenChief Executive Officer$9,480,974
Juan Carlos JaenPresident and Director$4,412,919
William GrossmanFormer Chief Medical Officer$3,926,548
Robert GoeltzChief Financial Officer$2,919,470
Carolyn Tang · this pageGeneral Counsel$2,916,407

The full Arcus Biosciences compensation record

free company brief

This page is one person within Arcus Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Arcus Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arcus Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Carolyn Tang's compensation dossier · One-time report. No refunds.